Header Logo

Connection

MATTHEW HAROLD KATZ to Patient Reported Outcome Measures

Back to Details
This is a "connection" page, showing publications MATTHEW HAROLD KATZ has written about Patient Reported Outcome Measures.
MATTHEW HAROLD KATZ
Connection Strength
0.154
Patient Reported Outcome Measures
  1. Patient-reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501). Ann Surg. 2023 10 01; 278(4):598-608.
    View in: PubMed
    Score: 0.154
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.